Ang Lifesciences India Ltd Share Price & Stock Analysis

Ang Lifesciences India Ltd (BSE: 540694) is an Amritsar, Punjab-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹49 Cr, it ranks #3,802 by market cap among the 6,197 Indian listed companies on FinBizNet, and #74 of 86 in Medicinal Chemicals and Botanical Products. At ₹40.20 (as of 16 Nov 2026), the share price is 19.1% below its 52-week high of ₹49.69 and 128.0% above its 52-week low of ₹17.63. The share price is up 33.8% over one year and up 31.0% over three months.

Key Metrics

Current Price₹40.20
Market Cap₹49 Cr
BSE Code540694
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E RatioNot meaningful (loss)
Return on Equity-17.70%
Return on Assets-1.45%
52-Week Range₹17.63 – ₹49.69
1-Year Price Change+33.8%
3-Month Price Change+31.0%
Beta (1Y)-0.6
Dividend Yield0.00%
HeadquartersAmritsar, Punjab
Websiteanglifesciences.com

Latest Quarterly Results — Q1 FY27

Revenue₹14 Cr
Net Profit₹-3 Cr
Net Margin-24.5%
EPS (Basic)₹2.59
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Ang Lifesciences India Ltd Quarterly Revenue and Profit Trend

Ang Lifesciences India Ltd reported revenue of ₹14 Cr in Q1 FY27, down 43.1% from ₹25 Cr in Q1 FY26 and down 38.8% from ₹23 Cr in Q4 FY26. It posted a net loss of ₹3 Cr for the quarter, against a net loss of ₹1 Cr in Q1 FY26. Across the 6 quarters from Q4 FY25 to Q1 FY27, quarterly revenue ranged from ₹14 Cr (Q1 FY27) to ₹26 Cr (Q2 FY26). The company reported a net loss in 5 of these 6 quarters.

QuarterRevenueNet ProfitNet Margin
Q1 FY27₹14 Cr−₹3 Cr−24.5%
Q4 FY26₹23 Cr₹1 Cr4.8%
Q3 FY26₹18 Cr−₹4 Cr−23.2%
Q2 FY26₹26 Cr−₹1 Cr−3.1%
Q1 FY26₹25 Cr−₹1 Cr−3.2%
Q4 FY25₹18 Cr−₹2 Cr−11.0%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 28.80% of Ang Lifesciences India Ltd's shares as of Mar 2026, against 35.55% in Mar 2025 (−6.75 percentage points). Delivery averaged 86.9% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Ang Lifesciences India Ltd

ANG Lifesciences India Limited engages in manufacturing and sale of finished pharmaceutical formulations in India and internationally. Its product portfolio comprises therapeutics categories, such as antibiotics, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, and beta lactamase inhibitor. The company offers its finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, PFS, hard gelatin capsules, soft gelatin capsules, dry syrups, liquid syrups and suspension, and lotions. ANG Lifesciences India Limited was incorporated in 2006 and is based in Amritsar, India.

Products and Services

1. Pharmaceuticals-This segment engages in the pharmaceutical business. 2. Printing and Packagings-This segment engages in the printing and packaging business. 3. Inter Segment Revenue-0

Business Segments

1. Pharmaceuticals-98.6% 2. Printing and Packagings-5.2%

Ang Lifesciences India Ltd vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Ang Lifesciences India Ltd₹49 Crn/m-17.70%₹14 Cr+33.8%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Ang Lifesciences India Ltd?

Ang Lifesciences India Ltd is trading at ₹40.20, with a market capitalisation of ₹49 Cr.

Which sector does Ang Lifesciences India Ltd belong to?

Ang Lifesciences India Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Ang Lifesciences India Ltd?

Ang Lifesciences India Ltd has a return on equity of -17.70%.

What is the stock symbol of Ang Lifesciences India Ltd?

Ang Lifesciences India Ltd is listed on the BSE under the scrip code 540694.

How has Ang Lifesciences India Ltd's share price moved over the past year?

Ang Lifesciences India Ltd's share price is up 33.8% over one year and up 31.0% over three months. Its 52-week range is ₹17.63 to ₹49.69.

What were Ang Lifesciences India Ltd's latest quarterly results?

In Q1 FY27, Ang Lifesciences India Ltd reported revenue of ₹14 Cr and net profit of ₹-3 Cr, with basic EPS of ₹2.59 (standalone, parsed from the company's exchange filing).

How have Ang Lifesciences India Ltd's revenue and profit changed over the past year?

Ang Lifesciences India Ltd reported revenue of ₹14 Cr in Q1 FY27, down 43.1% from ₹25 Cr in Q1 FY26 and down 38.8% from ₹23 Cr in Q4 FY26.

What is the promoter holding in Ang Lifesciences India Ltd?

Promoters held 28.80% of Ang Lifesciences India Ltd's shares as of Mar 2026, against 35.55% in Mar 2025 (−6.75 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.